Procter & Gamble Health Stock

Procter & Gamble Health P/S 2025

Procter & Gamble Health P/S

6.62

Ticker

PGHL.NS

ISIN

INE199A01012

As of Mar 6, 2025, Procter & Gamble Health's P/S ratio stood at 6.62, a -12.32% change from the 7.55 P/S ratio recorded in the previous year.

The Procter & Gamble Health P/S history

Procter & Gamble Health Aktienanalyse

What does Procter & Gamble Health do?

Procter & Gamble Health Ltd. is a leading company in the health and hygiene products industry. The company was founded in 1837 by William Procter and James Gamble in Cincinnati, Ohio. Since then, the company has undergone incredible development and is now a global corporation with more than 95,000 employees and an annual revenue of nearly $70 billion. The business model of Procter & Gamble Health Ltd. is focused on providing customers with high-quality products at an affordable price. The company operates in various areas, including household products, health products, beauty products, and hygiene products. The different divisions of Procter & Gamble Health Ltd. include the following areas: Household products: Brands like Ariel, Ace, and Lenor are among the most well-known offerings from Procter & Gamble Health. The company is also active in the textile care category and offers various products such as the brand Downy. Health products: The company's health products focus on oral and dental care, as well as pain relief and digestive aids. Brands like Oral-B and Vick are among the most well-known in the portfolio. Beauty products: Procter & Gamble Health offers a wide range of beauty products such as shampoo, conditioner, and hair dye. Herbal Essences, Pantene, and Wella are among the most well-known brands in this area. Hygiene products: The company offers products such as toilet paper, diapers, and cleaning agents. Pampers, Charmin, and Swiffer are among the most well-known brands. Procter & Gamble Health Ltd. has a very extensive product portfolio, which also includes brands like Always, Old Spice, and Gillette. Procter & Gamble Health is an innovative company that continuously offers its customers new and improved products. An example of this is the development of Tide Pods, a novel way to wash laundry that is packaged in a completely soluble shell. In addition to continuous product development, the company also places great importance on sustainability and social responsibility. Procter & Gamble Health actively engages in environmental protection and advocates for the improvement of working conditions and quality of life for people worldwide. In summary, Procter & Gamble Health Ltd. is a successful company that enjoys an excellent reputation due to its innovative strength, extensive product range, and commitment to sustainability and social responsibility. Procter & Gamble Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Procter & Gamble Health's P/S Ratio

Procter & Gamble Health's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Procter & Gamble Health's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Procter & Gamble Health's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Procter & Gamble Health’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Procter & Gamble Health stock

What is the price-to-earnings ratio of Procter & Gamble Health?

The price-earnings ratio of Procter & Gamble Health is currently 6.62.

How has the price-earnings ratio of Procter & Gamble Health changed compared to last year?

The price-to-earnings ratio of Procter & Gamble Health has increased by -12.32% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Procter & Gamble Health high compared to other companies?

Yes, the price-to-earnings ratio of Procter & Gamble Health is high compared to other companies.

How does an increase in the price-earnings ratio of Procter & Gamble Health affect the company?

An increase in the price-earnings ratio of Procter & Gamble Health would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Procter & Gamble Health affect the company?

A decrease in the price-earnings ratio of Procter & Gamble Health would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Procter & Gamble Health?

Some factors that influence the price-earnings ratio of Procter & Gamble Health are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Procter & Gamble Health pay?

Over the past 12 months, Procter & Gamble Health paid a dividend of 270 INR . This corresponds to a dividend yield of about 5.29 %. For the coming 12 months, Procter & Gamble Health is expected to pay a dividend of 306.55 INR.

What is the dividend yield of Procter & Gamble Health?

The current dividend yield of Procter & Gamble Health is 5.29 %.

When does Procter & Gamble Health pay dividends?

Procter & Gamble Health pays a quarterly dividend. This is distributed in the months of December, March, December, March.

How secure is the dividend of Procter & Gamble Health?

Procter & Gamble Health paid dividends every year for the past 14 years.

What is the dividend of Procter & Gamble Health?

For the upcoming 12 months, dividends amounting to 306.55 INR are expected. This corresponds to a dividend yield of 6.01 %.

In which sector is Procter & Gamble Health located?

Procter & Gamble Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Procter & Gamble Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Procter & Gamble Health from 3/7/2025 amounting to 80 INR, you needed to have the stock in your portfolio before the ex-date on 2/21/2025.

When did Procter & Gamble Health pay the last dividend?

The last dividend was paid out on 3/7/2025.

What was the dividend of Procter & Gamble Health in the year 2024?

In the year 2024, Procter & Gamble Health distributed 145 INR as dividends.

In which currency does Procter & Gamble Health pay out the dividend?

The dividends of Procter & Gamble Health are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Procter & Gamble Health

Our stock analysis for Procter & Gamble Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Procter & Gamble Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.